- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Integrated Research Ltd (IRI)
Integrated Research Ltd stock price live, this page displays ASX IRI stock exchange data. View the IRI premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Integrated Research Ltd real time stock price chart below.
What Is the Integrated Research Ltd Stock Price Today?
The Integrated Research Ltd stock price today is 0.290.
What Is the Stock Symbol for Integrated Research Ltd?
The stock symbol for Integrated Research Ltd is "IRI."
What Stock Exchange Does Integrated Research Ltd Trade On?
Integrated Research Ltd is listed and trades on the Sydney stock exchange.
Is Integrated Research Ltd a Good Stock to Buy?
Determining whether Integrated Research Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRI quote. (ISIN: AU000000IRI3)
What Is the Integrated Research Ltd Stock Price Today?
The Integrated Research Ltd stock price today is 0.290.
What Is the Stock Symbol for Integrated Research Ltd?
The stock symbol for Integrated Research Ltd is "IRI."
What Stock Exchange Does Integrated Research Ltd Trade On?
Integrated Research Ltd is listed and trades on the Sydney stock exchange.
Is Integrated Research Ltd a Good Stock to Buy?
Determining whether Integrated Research Ltd, or any stock, is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IRI quote. (ISIN: AU000000IRI3)
Sydney
Currency in AUD
0.290
-0.010(-3.33%)
Closed·
Fair Value
An estimate of a Integrated Research's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.290
0.300
52 wk Range
0.270
0.430
High dividend Yield
1/2
Fair Value
An estimate of a Integrated Research's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.2900.300
52 wk Range
0.2700.430
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(16.67%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(16.67%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IRI Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Integrated Research's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
0.360
Upside
+24.14%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
High shareholder yield
IR Announces Enhanced Cisco Cloud Migration Support- Investing.com
- IR Announces Enhanced Cisco Cloud Migration Support
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
0 Buy
1 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 0.360
(+24.14% Upside)
Integrated Research Ltd Earnings Call Summary for H1/2026
- Revenue fell 2% to 28.3M AUD on softer renewals; EBITDA swung to 3.1M AUD loss from 4.6M profit year-over-year, driving 6.25% stock decline.
- Launched AI-powered product Iris with positive feedback; planning standalone AI product from IR Labs as part of product-led growth strategy transition.
- Operating cash flow surged to 5.5M AUD from 0.5M AUD; cash balance rose 8% to 43.6M AUD despite 1.5M AUD net loss after tax.
- Management forecasts FY2026 EPS of 0.07 USD and revenue of 94.71M USD; Iris rollout expected complete by end of FY26 across all product lines.
- Americas market declined 6%; faces headwinds from client churn, significant credit loss from single client, and competitive pressure in observability market.
Last Updated: 26/02/2026, 01:24
Read Full TranscriptEarnings
Latest Release
Aug 26, 2026
EPS / Forecast
0.01 / --
Revenue / Forecast
29.29M / 37.4M
Compare IRI to Peers and Sector
Metrics to compare | IRI | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipIRIPeersSector | |
|---|---|---|---|---|
P/E Ratio | 41.8x | 13.5x | 12.1x | |
PEG Ratio | −0.46 | 0.06 | 0.01 | |
Price/Book | 0.5x | 2.6x | 2.4x | |
Price / LTM Sales | 0.9x | 2.1x | 2.2x | |
Upside (Analyst Target) | 24.1% | 44.8% | 36.0% | |
Fair Value Upside | Unlock | 29.2% | 6.2% | Unlock |
Integrated Research Limited engages in the design, development, implementation, and sale of software to monitor the performance of business-critical computing. The company offers Prognosis, an integrated suite of monitoring and management software for operational insight and optimize operation of HP NonStop, distributed system servers, Unified Communications, and payment environments, and business applications. It also provides Iris, a natural language AI; Elevate, a platform delivered as a service; maintenance, SaaS, testing solutions, and professional services. The company serves banks, credit card companies, telecommunications carriers, technology companies, service providers, and manufacturers through direct sales operations and channel-driven distribution networks in the United States, United Kingdom, Germany, Singapore, Australia, and internationally. Integrated Research Limited was incorporated in 1988 and is based in Sydney, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Integrated Research (IRI) Stock Price Today?
The Integrated Research stock price today is 0.290 AUD.
What Stock Exchange Does Integrated Research Trade On?
Integrated Research is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Integrated Research?
The stock symbol for Integrated Research is "IRI."
What Is the Integrated Research Market Cap?
As of today, Integrated Research market cap is 52.370M AUD.
What Is Integrated Research's Earnings Per Share (TTM)?
The Integrated Research EPS (TTM) is 0.007.
From a Technical Analysis Perspective, Is IRI a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Integrated Research Stock Split?
Integrated Research has split 0 times.
How Many Employees Does Integrated Research Have?
Integrated Research has 138 employees.
What is the current trading status of Integrated Research (IRI)?
As of Sep 04, 2026, Integrated Research (IRI) is trading at a price of 0.290 AUD, with a previous close of 0.300 AUD. The stock has fluctuated within a day range of 0.290 AUD to 0.300 AUD, while its 52-week range spans from 0.270 AUD to 0.430 AUD.
What Is Integrated Research (IRI) Price Target According to Analysts?
The average 12-month price target for Integrated Research is 0.360 AUD, with a high estimate of 0.36 AUD and a low estimate of 0.36 AUD. 0 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Neutral. The stock has an +24.14% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.